Preliminary efficacy and tolerability of oral NCX-1000 after repeated administrations to patients with portal hypertension.Double-blind study with increasing dose [Eficacia y tolerabilidad preliminar del NCX-1000 oral después de repetidas administraciones a pacientes con hipertensión portal. Estudio a doble ciego con dosis creciente]
Latest Information Update: 13 Apr 2022
At a glance
- Drugs NCX 1000 (Primary)
- Indications Portal hypertension
- Focus Therapeutic Use
- Sponsors Adare Pharmaceuticals
- 13 Apr 2022 New trial record